πŸ‡ΊπŸ‡Έ FDA
Patent

US 6333331

Substituted O6-benzylguanines

expired A61PA61P35/00A61P43/00

Quick answer

US patent 6333331 (Substituted O6-benzylguanines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00, A61P43/00